The Expression Pattern of the AML1 Gene in Non-Hodgkin's B-Cell Lymphomas and Normal B Lymphocytes

By Chimienti G.   Alaibac M.   Marzullo F.   Carbone A.   Pepe G.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 3, 2000-06 ,pp. : 186-192

Academic Press

Access to resources Recommend Favorite

Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin's lymphoma in the same patient

By Ianotto Jean-Christophe  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 273-274

Springer Publishing Company

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

By Ruiz-Delgado Guillermo J   Gómez-Almaguer David   Tarín-Arzaga Luz C   Cantú-Rodriguez Olga G   Urdaneta Carlos Alarcón   Rodríguez-Morales Uxmal   Calderón-Garcia Jackeline   Fernández-Vargas Omar   Montes-Montiel Maryel   Sánchez-Cárdenas Mónica   Ruiz-Argüelles Guillermo J  

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 193-197

Maney Publishing

Access to resources Recommend Favorite

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas - reactivity toward the malignant clone

By Chaperot L.   Plumas J.   Jacob M.-C.   Bost F.   Molens J.-P.   Sotto J.-J.   Bensa J.-C.  

Experimental Hematology, Vol. 27, Iss. 3, 1999-03 ,pp. : 479-488

Elsevier

Access to resources Recommend Favorite